120 related articles for article (PubMed ID: 2661085)
1. Tumour reduction and chemotherapy in ovarian cancer.
Pfleiderer A
Baillieres Clin Obstet Gynaecol; 1989 Mar; 3(1):119-28. PubMed ID: 2661085
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of residual tumour volume in stage III ovarian cancer patients undergoing adjuvant cytotoxic chemotherapy.
Petru E; Lahousen M; Tamussino K; Pickel H; Stettner H
Baillieres Clin Obstet Gynaecol; 1989 Mar; 3(1):109-17. PubMed ID: 2661084
[TBL] [Abstract][Full Text] [Related]
3. [Control of the response of ovarian cancers to cytostatic therapy and the value of the second-look operation].
Teufel G; Meerpohl HG; Pfleiderer A
Onkologie; 1985 Dec; 8(6):356-63. PubMed ID: 3912693
[TBL] [Abstract][Full Text] [Related]
4. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
5. [The surgical treatment of ovarian cancer].
Burghardt E; Lahousen M; Stettner H
Geburtshilfe Frauenheilkd; 1990 Sep; 50(9):670-7. PubMed ID: 2272432
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Williams K; Senterman M; Hopkins L; Faught W; Fung-Kee-Fung M
Gynecol Oncol; 2007 Jul; 106(1):160-3. PubMed ID: 17490737
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
8. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
9. [The second-look operation in advanced ovarian cancer--experiences since the introduction of cisplatin combination chemotherapy].
Kaufmann M; Hanke J; Schmid H; Kühn W; Kubli F
Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):581-7. PubMed ID: 3770408
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
Sun T; Feng Y; Zhu Y; Zheng Y
Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of advanced ovarian cancer as an interdisciplinary task: surgery, histopathology, radiotherapy, and chemotherapy].
Szepesi T; Szalay S; Breitenecker G; Schratter-Sehn A; Rogan AM; Riss T; Wittich G; Heckenthaler W; Fasching W; Scheiber V
Wien Klin Wochenschr; 1983 Jan; 95(2):37-49. PubMed ID: 6190318
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
Tang L; Zheng M; Xiong Y; Ding H; Liu FY
Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
[TBL] [Abstract][Full Text] [Related]
13. Intestinal metastasis and operation in ovarian cancer: a report on 62 cases.
Wu PC; Lang JH; Huang RL; Liu J; Tang MY; Lian LJ
Baillieres Clin Obstet Gynaecol; 1989 Mar; 3(1):95-108. PubMed ID: 2472246
[TBL] [Abstract][Full Text] [Related]
14. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum.
Gronlund B; Lundvall L; Christensen IJ; Knudsen JB; Høgdall C
Eur J Surg Oncol; 2005 Feb; 31(1):67-73. PubMed ID: 15642428
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
16. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Aghajanian C; Barakat RR; Chi DS
Gynecol Oncol; 2008 Feb; 108(2):276-81. PubMed ID: 18063020
[TBL] [Abstract][Full Text] [Related]
17. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
Tkácová M; Vertaková-Krakovská B; Belohorská B; Miskovská V; Helpianska L; Ondrus D; Ondrusová M; Spánik S; Svec J
Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
[TBL] [Abstract][Full Text] [Related]
18. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer].
Meier W; Römisch M; Hepp H
Geburtshilfe Frauenheilkd; 1993 Dec; 53(12):860-5. PubMed ID: 8119569
[TBL] [Abstract][Full Text] [Related]
19. Epithelial ovarian carcinoma: principles of primary surgery.
Hoskins WJ
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S91-6. PubMed ID: 7835815
[TBL] [Abstract][Full Text] [Related]
20. [Ovarian cancer (experience with 186 patients)].
Torres Lobaton A; Matías Salvador JM; Herrera R; Gerson R; Román Bassaure E
Ginecol Obstet Mex; 1992 Sep; 60():241-6. PubMed ID: 1398206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
